XML 135 R35.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SHARE-BASED COMPENSATION (Tables)
12 Months Ended
Oct. 31, 2019
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Allocated Share-based compensation expense disclosure
The impact on our results for share-based compensation was as follows:

 
Years Ended October 31,
 
2019
 
2018
 
2017
 
(in millions)
Cost of products and services
$
18

 
$
16

 
$
15

Research and development
7

 
7

 
6

Selling, general and administrative
47

 
48

 
40

Total share-based compensation expense
$
72

 
$
71

 
$
61


Share-based compensation arrangement by share-based payment award fair value assumptions and methodology schedule
The following assumptions were used to estimate the fair value of awards granted.

 
Years Ended October 31,
 
2019
 
2018
 
2017
LTPP:
 
 
 
 
 
Volatility of Agilent shares
22%
 
21%
 
23%
Volatility of selected peer-company shares
15%-66%
 
14%-66%
 
15%-63%
Pair-wise correlation with selected peers
30%
 
32%
 
36%
 
 
 
 
 
 
Post-vest restriction discount for all executive awards
5.0%
 
4.8%
 
5.3%

Summary of stock option award activity
The following table summarizes employee stock option award activity of our employees and directors for 2019.

 
Options
Outstanding
 
Weighted
Average
Exercise Price
 
(in thousands)
 
 
Outstanding at October 31, 2018
1,997

 
$
35

Exercised
(552
)
 
$
33

Forfeited

 
$

Outstanding at October 31, 2019
1,445

 
$
36


Schedule of share-based compensation, shares authorized under stock option plans, by exercise price range
The options outstanding and exercisable for equity share-based payment awards at October 31, 2019 were as follows:

 
Options Outstanding
 
Options Exercisable
Range of
Exercise Prices
Number
Outstanding
 
Weighted
Average
Remaining
Contractual
Life
 
Weighted
Average
Exercise
Price
 
Aggregate
Intrinsic
Value
 
Number
Exercisable
 
Weighted
Average
Remaining
Contractual
Life
 
Weighted
Average
Exercise
Price
 
Aggregate
Intrinsic
Value
 
(in thousands)
 
(in years)
 
 
 
(in thousands)
 
(in thousands)
 
(in years)
 
 
 
(in thousands)
$25.01 - 30
483

 
2.5
 
$
26

 
23,769

 
483

 
2.5
 
$
26

 
23,769

$30.01 - 40
296

 
4.1
 
$
39

 
10,845

 
296

 
4.1
 
$
39

 
10,845

$40.01 - over
666

 
5.0
 
$
41

 
23,211

 
666

 
5.0
 
$
41

 
23,211

 
1,445

 
4.0
 
$
36

 
$
57,825

 
1,445

 
4.0
 
$
36

 
$
57,825


Schedule of intrinsic value of options exercised and the fair value of options granted
The following table summarizes the aggregate intrinsic value of options exercised in 2019, 2018 and 2017:

 
Aggregate
Intrinsic Value
 
Weighted
Average
Exercise
Price
 
(in thousands)
 
 
Options exercised in fiscal 2017
$
36,175

 
$
30

Options exercised in fiscal 2018
$
28,417

 
$
32

Options exercised in fiscal 2019
$
24,409

 
$
33


Non-vested award activity disclosure
The following table summarizes non-vested award activity in 2019 primarily for our LTPP and restricted stock unit awards.
 
Shares
 
Weighted
Average
Grant Price
 
(in thousands)
 
 
Non-vested at October 31, 2018
3,181

 
$
57

Granted
1,309

 
$
68

Vested
(1,530
)
 
$
45

Forfeited
(78
)
 
$
60

Change in LTPP shares in the year due to exceeding performance targets
291

 
$

Non-vested at October 31, 2019
3,173

 
$
60